146 related articles for article (PubMed ID: 33507341)
21. Long non-coding RNAs defining major subtypes of B cell precursor acute lymphoblastic leukemia.
James AR; Schroeder MP; Neumann M; Bastian L; Eckert C; Gökbuget N; Tanchez JO; Schlee C; Isaakidis K; Schwartz S; Burmeister T; von Stackelberg A; Rieger MA; Göllner S; Horstman M; Schrappe M; Kirschner-Schwabe R; Brüggemann M; Müller-Tidow C; Serve H; Akalin A; Baldus CD
J Hematol Oncol; 2019 Jan; 12(1):8. PubMed ID: 30642353
[TBL] [Abstract][Full Text] [Related]
22. Deep targeted sequencing in pediatric acute lymphoblastic leukemia unveils distinct mutational patterns between genetic subtypes and novel relapse-associated genes.
Lindqvist CM; Lundmark A; Nordlund J; Freyhult E; Ekman D; Carlsson Almlöf J; Raine A; Övernäs E; Abrahamsson J; Frost BM; Grandér D; Heyman M; Palle J; Forestier E; Lönnerholm G; Berglund EC; Syvänen AC
Oncotarget; 2016 Sep; 7(39):64071-64088. PubMed ID: 27590521
[TBL] [Abstract][Full Text] [Related]
23. Low expression of
Cui L; Gao C; Wang CJ; Liu SG; Wu MY; Zhang RD; Li ZG
Pediatr Hematol Oncol; 2020 Nov; 37(8):732-746. PubMed ID: 32804017
[TBL] [Abstract][Full Text] [Related]
24. Circulating follicular T helper cells are possibly associated with low levels of serum immunoglobulin G due to impaired immunoglobulin class-switch recombination of B cells in children with primary nephrotic syndrome.
Yang X; Tang X; Li T; Man C; Yang X; Wang M; Zhang G; Chen Y; Yang H; Li Q
Mol Immunol; 2019 Oct; 114():162-170. PubMed ID: 31352232
[TBL] [Abstract][Full Text] [Related]
25. T cells stimulated by CD40L positive leukemic blasts-pulsed dendritic cells meet optimal functional requirements for adoptive T-cell therapy.
D'Amico G; Bonamino M; Dander E; Marin V; Basso G; Balduzzi A; Biagi E; Biondi A
Leukemia; 2006 Nov; 20(11):2015-24. PubMed ID: 16990769
[TBL] [Abstract][Full Text] [Related]
26. Heterogeneity of childhood acute leukemia with mature B-cell immunophenotype.
Demina I; Zerkalenkova E; Illarionova O; Olshanskaya Y; Verzhbitskaya T; Semchenkova A; Tsaur G; Rusanova E; Belogurova M; Baidun L; Plyasunova S; Konyuhova T; Kazakova A; Fechina L; Novichkova G; Samochatova E; Myakova N; Maschan A; Popov AM
J Cancer Res Clin Oncol; 2019 Nov; 145(11):2803-2811. PubMed ID: 31463716
[TBL] [Abstract][Full Text] [Related]
27. Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.
Engels K; Jungnickel B; Tobollik S; Hansmann ML; Kriener S; Willenbrock K
Appl Immunohistochem Mol Morphol; 2008 Dec; 16(6):521-9. PubMed ID: 18776814
[TBL] [Abstract][Full Text] [Related]
28. Efficient Induction of Ig Gene Hypermutation in Ex Vivo-Activated Primary B Cells.
Liu J; Xiong E; Zhu H; Mori H; Yasuda S; Kinoshita K; Tsubata T; Wang JY
J Immunol; 2017 Nov; 199(9):3023-3030. PubMed ID: 28939756
[TBL] [Abstract][Full Text] [Related]
29. Differential expression of CD73, CD86 and CD304 in normal vs. leukemic B-cell precursors and their utility as stable minimal residual disease markers in childhood B-cell precursor acute lymphoblastic leukemia.
Sędek Ł; Theunissen P; Sobral da Costa E; van der Sluijs-Gelling A; Mejstrikova E; Gaipa G; Sonsala A; Twardoch M; Oliveira E; Novakova M; Buracchi C; van Dongen JJM; Orfao A; van der Velden VHJ; Szczepański T;
J Immunol Methods; 2019 Dec; 475():112429. PubMed ID: 29530508
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-7 signaling in human B cell precursor acute lymphoblastic leukemia cells and murine BAF3 cells involves activation of STAT1 and STAT5 mediated via the interleukin-7 receptor alpha chain.
van der Plas DC; Smiers F; Pouwels K; Hoefsloot LH; Löwenberg B; Touw IP
Leukemia; 1996 Aug; 10(8):1317-25. PubMed ID: 8709637
[TBL] [Abstract][Full Text] [Related]
31. Expression of interleukin-4 receptors on early human B-lineage cells.
Law CL; Armitage RJ; Villablanca JG; LeBien TW
Blood; 1991 Aug; 78(3):703-10. PubMed ID: 1859884
[TBL] [Abstract][Full Text] [Related]
32. Human activation-induced cytidine deaminase is induced by IL-4 and negatively regulated by CD45: implication of CD45 as a Janus kinase phosphatase in antibody diversification.
Zhou C; Saxon A; Zhang K
J Immunol; 2003 Feb; 170(4):1887-93. PubMed ID: 12574355
[TBL] [Abstract][Full Text] [Related]
33. Establishment of novel B-cell precursor leukemia sister cell lines NALM-36 and NALM-37: shift of immunoglobulin phenotype to double light chain positive B-cell.
Matsuo Y; Drexler HG; Takeuchi M; Orita K
Leuk Res; 2002 Jan; 26(1):1-10. PubMed ID: 11734297
[TBL] [Abstract][Full Text] [Related]
34. Establishment of cell lines from B-cell precursor acute lymphoblastic leukemia.
Zhang LQ; Downie PA; Goodell WR; McCabe NR; LeBeau MM; Morgan R; Sklar J; Raimondi SC; Miley D; Goldberg A
Leukemia; 1993 Nov; 7(11):1865-74. PubMed ID: 8231254
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow stroma-derived PGE2 protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death.
Naderi EH; Skah S; Ugland H; Myklebost O; Sandnes DL; Torgersen ML; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Mol Cancer; 2015 Jan; 14(1):14. PubMed ID: 25623255
[TBL] [Abstract][Full Text] [Related]
36. p21(WAF1) modulates drug-induced apoptosis and cell cycle arrest in B-cell precursor acute lymphoblastic leukemia.
Davies C; Hogarth LA; Mackenzie KL; Hall AG; Lock RB
Cell Cycle; 2015; 14(22):3602-12. PubMed ID: 26506264
[TBL] [Abstract][Full Text] [Related]
37. Activation-induced cytidine deaminase fails to induce a mutator phenotype in the human pre-B cell line Nalm-6.
Rückerl F; Bachl J
Eur J Immunol; 2005 Jan; 35(1):290-8. PubMed ID: 15593119
[TBL] [Abstract][Full Text] [Related]
38. Selective inhibition of cell death in malignant vs normal B-cell precursors: implications for cAMP in development and treatment of BCP-ALL.
Naderi EH; Ugland HK; Diep PP; Josefsen D; Ruud E; Naderi S; Blomhoff HK
Blood; 2013 Mar; 121(10):1805-13. PubMed ID: 23299313
[TBL] [Abstract][Full Text] [Related]
39. AID-induced T-lymphoma or B-leukemia/lymphoma in a mouse BMT model.
Komeno Y; Kitaura J; Watanabe-Okochi N; Kato N; Oki T; Nakahara F; Harada Y; Harada H; Shinkura R; Nagaoka H; Hayashi Y; Honjo T; Kitamura T
Leukemia; 2010 May; 24(5):1018-24. PubMed ID: 20357822
[TBL] [Abstract][Full Text] [Related]
40. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
